Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China
· Delayed Price · Currency is CNY 15.65
-0.45 (-2.80%)
At close: Jul 4, 2025, 2:57 PM CST
SHE:301246 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2015 - 2019 |
Net Income | 29.15 | 51.47 | 87.17 | 434.8 | 493.85 | 257.18 | Upgrade
|
Depreciation & Amortization | 178.6 | 178.6 | 156.88 | 89.8 | 80.36 | 74.37 | Upgrade
|
Other Amortization | 3.39 | 3.39 | 4.44 | 6.14 | 5.52 | 3.11 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.53 | -0.53 | -0.57 | -14.44 | 0 | -1.88 | Upgrade
|
Asset Writedown & Restructuring Costs | 0.27 | 0.27 | - | 1.97 | 7.88 | 9.89 | Upgrade
|
Loss (Gain) From Sale of Investments | -5.24 | -5.24 | -20.99 | -169.14 | -190.23 | 15.15 | Upgrade
|
Provision & Write-off of Bad Debts | 0.51 | 0.51 | -2.55 | 4.29 | 1.03 | 0.07 | Upgrade
|
Other Operating Activities | 35.86 | 47.63 | 46.45 | 38.7 | 7.45 | 21.13 | Upgrade
|
Change in Accounts Receivable | - | - | - | -494.66 | -289.98 | -155.24 | Upgrade
|
Change in Inventory | -74.75 | -74.75 | 135.06 | -178.49 | -81.72 | -63.5 | Upgrade
|
Change in Accounts Payable | -226.16 | -226.16 | -374.53 | 498.4 | 165.33 | -18.51 | Upgrade
|
Change in Other Net Operating Assets | 8.62 | 8.62 | - | - | - | - | Upgrade
|
Operating Cash Flow | -49.9 | -15.81 | 35.25 | 214.99 | 196.1 | 142.39 | Upgrade
|
Operating Cash Flow Growth | - | - | -83.60% | 9.63% | 37.71% | -39.72% | Upgrade
|
Capital Expenditures | -31.82 | -160.2 | -474.64 | -507.09 | -259.01 | -56.86 | Upgrade
|
Sale of Property, Plant & Equipment | 1.35 | 1.36 | 1.14 | 104.26 | 1.33 | 152.75 | Upgrade
|
Cash Acquisitions | -3.2 | -3.2 | - | - | - | - | Upgrade
|
Investment in Securities | -30.07 | 575.55 | -1,596 | 33 | 0.01 | 2.87 | Upgrade
|
Other Investing Activities | -61.5 | - | - | - | - | 0.79 | Upgrade
|
Investing Cash Flow | -125.25 | 413.51 | -2,069 | -369.83 | -257.67 | 99.55 | Upgrade
|
Long-Term Debt Issued | - | 51.14 | 21.25 | 494.5 | 110 | 199.98 | Upgrade
|
Total Debt Issued | 169.51 | 51.14 | 21.25 | 494.5 | 110 | 199.98 | Upgrade
|
Long-Term Debt Repaid | - | -66.9 | -98.28 | -55.07 | -188.85 | -354.46 | Upgrade
|
Total Debt Repaid | -71.9 | -66.9 | -98.28 | -55.07 | -188.85 | -354.46 | Upgrade
|
Net Debt Issued (Repaid) | 97.61 | -15.76 | -77.02 | 439.43 | -78.85 | -154.48 | Upgrade
|
Issuance of Common Stock | - | - | 2,196 | - | - | - | Upgrade
|
Repurchase of Common Stock | -32.8 | -32.8 | - | - | - | - | Upgrade
|
Common Dividends Paid | -27.96 | -30.86 | -53.8 | -14.97 | -2.22 | -8.74 | Upgrade
|
Dividends Paid | -27.96 | -30.86 | -53.8 | -14.97 | -2.22 | -8.74 | Upgrade
|
Other Financing Activities | -90.55 | -97.48 | 88.07 | -134.32 | 15.27 | 8.68 | Upgrade
|
Financing Cash Flow | -53.7 | -176.9 | 2,153 | 290.13 | -65.79 | -154.54 | Upgrade
|
Foreign Exchange Rate Adjustments | 4.35 | 4.98 | 0.57 | 5.65 | -1.13 | -7.57 | Upgrade
|
Net Cash Flow | -224.5 | 225.78 | 119.68 | 140.94 | -128.49 | 79.83 | Upgrade
|
Free Cash Flow | -81.72 | -176.01 | -439.39 | -292.1 | -62.92 | 85.53 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | - | -36.51% | Upgrade
|
Free Cash Flow Margin | -4.60% | -9.94% | -21.38% | -14.15% | -3.99% | 6.57% | Upgrade
|
Free Cash Flow Per Share | -0.20 | -0.44 | -1.13 | -0.83 | -0.18 | 0.24 | Upgrade
|
Cash Income Tax Paid | - | -19.15 | 67.14 | 45.74 | 89.49 | 87.38 | Upgrade
|
Levered Free Cash Flow | -140.88 | 187.98 | -511.52 | 120.97 | 53.49 | 213.49 | Upgrade
|
Unlevered Free Cash Flow | -133.06 | 195.48 | -503.15 | 123.1 | 54.98 | 223.15 | Upgrade
|
Change in Net Working Capital | 294.29 | -151.63 | 229.79 | -370.84 | -5.54 | 18.57 | Upgrade
|
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.